| 1991 |
HSF2 encodes a protein that binds heat shock elements (HSEs) with specificity identical to HeLa HSF and stimulates transcription from a heat shock promoter, establishing it as a distinct human heat shock transcription factor paralog separate from HSF1. |
cDNA cloning, in vitro DNA-binding assay, transcriptional reporter assay, antibody cross-reactivity |
Proceedings of the National Academy of Sciences of the United States of America |
High |
1871106
|
| 1994 |
HSF2 forms trimers and binds HSEs composed of alternating inverted pentameric nGAAn repeats, but exhibits less cooperative DNA binding than HSF1; sequences within or adjacent to the HSF1 DNA-binding domain (not shared by HSF2) confer the higher cooperativity to HSF1, as demonstrated by chimeric HSF1/HSF2 proteins. |
In vitro DNA-binding selection (SELEX), mutagenesis of HSEs, chimeric protein analysis, gel-shift assays |
Molecular and cellular biology |
High |
7935474
|
| 1994 |
HSF2 is present as a trimer in mouse embryonal carcinoma (EC) cells and exhibits constitutive HSE-binding activity, but trimerization and nuclear localization of HSF2 are not sufficient for in vivo binding to the hsp70 HSE in unstressed EC cells, and HSF2 does not stimulate hsp70 or hsp86 transcription under these conditions. |
Gel-shift assay, transcription run-on assay, genomic footprinting, immunoblotting |
Molecular and cellular biology |
High |
8035809
|
| 1998 |
HSF2 activation is triggered by inhibition of the ubiquitin-proteasome pathway; HSF2 is a labile protein whose activation requires both continued protein synthesis and reduced proteasomal degradation, establishing proteasome dysfunction as a stress signal for HSF2. |
Proteasome inhibitor treatment (hemin, MG132, lactacystin), ts85 cell line (E1 ubiquitin-activating enzyme mutant), DNA-binding assays, immunoblotting |
Molecular and cellular biology |
High |
9710593
|
| 2000 |
HSF2 physically interacts with the PR65/A scaffolding subunit of PP2A and competes with the PP2A catalytic subunit for binding; this competition maps to lysine 416 within the intra-repeat loop of HEAT repeat 11 of PR65, shared by both HSF2 and the catalytic subunit binding interface. |
Co-immunoprecipitation, pulldown with point mutants of PR65 |
Biochemical and biophysical research communications |
Medium |
10872807
|
| 2003 |
HSF2-null mice exhibit brain abnormalities (enlarged lateral and third ventricles, reduced hippocampus and striatum), meiotic defects in spermatogenesis (apoptosis of spermatocytes, synaptonemal complex structural defects), and female subfertility, demonstrating essential roles in brain development and gametogenesis. |
Targeted gene disruption (knockout mouse), histology, immunohistochemistry |
The EMBO journal |
High |
12032072 12748967
|
| 2003 |
HSF2 physically interacts with HSF1 and localizes to nuclear stress granules upon heat shock; deletion mutant analysis shows HSF2 influences HSF1 localization to stress granules; stress granule dynamics coincide with nucleolar Hsp70 accumulation. |
Co-immunoprecipitation, immunofluorescence, deletion mutant analysis, live-cell imaging |
Journal of cell science |
Medium |
12865437
|
| 2004 |
Genetic disruption of both hsf1 and hsf2 causes male sterility with more severe spermatogenesis defects than either single knockout alone, including failure of germ cells to progress past pachytene and loss of transcription of spermatogenesis-specific genes, demonstrating additive/synergistic transcriptional roles in spermatogenesis. |
Double-knockout mouse genetics, histology, RT-PCR |
Genesis |
High |
14994269
|
| 2006 |
Upon proteasome inhibition, HSF1 and HSF2 form heterocomplexes that bind to the clusterin heat shock element (CLE) and activate clusterin transcription; gel-filtration indicates these heterocomplexes have the same apparent mass as HSF1 homotrimers, suggesting HSF1-HSF2 heterotrimer formation. |
Gel mobility-shift assay, supershift assay, chromatin immunoprecipitation (ChIP), co-immunoprecipitation, gel-filtration analysis, promoter deletion/mutation studies |
The Biochemical journal |
High |
16336210
|
| 2007 |
HSF2 participates in heat-shock-inducible hsp70 promoter occupancy and modulates HSF1-mediated Hsp gene expression; intact HSF1 is required for maximal HSF2 promoter occupancy, indicating HSF1 influences HSF2 DNA-binding activity at the hsp70 promoter. |
Chromatin immunoprecipitation (ChIP), real-time RT-PCR, HSF2 knockdown/overexpression |
The Journal of biological chemistry |
High |
17213196
|
| 2007 |
HSF2 binds constitutively to HSE elements in the Hsp90, Hsp27, and c-Fos promoters during mitosis (gene bookmarking); RNAi-mediated reduction of HSF2 leads to decreased protein levels of Hsp90, Hsp27, and c-Fos, establishing HSF2 as required for their expression. |
Chromatin immunoprecipitation, RNA interference (RNAi), immunoblotting |
Cell stress & chaperones |
Medium |
17915561
|
| 2008 |
HSF2 interacts with the polycomb protein MEL-18 and the SUMO E2 enzyme UBC9; MEL-18 binding to HSF2 inhibits HSF2 sumoylation by blocking UBC9 activity; this interaction decreases during mitosis, explaining the observed increase in HSF2 sumoylation during mitosis. |
Co-immunoprecipitation, RNA interference, overexpression, sumoylation assay |
The Journal of biological chemistry |
Medium |
18211895
|
| 2008 |
HSF2 occupies Y chromosome MSYq gene promoters in mouse testis in vivo; HSF2 disruption causes reduced expression of MSYq-resident multicopy genes, sperm head abnormalities, altered chromatin packing proteins, and increased sperm DNA fragmentation, defining HSF2 as a regulator of Y-chromosome gene transcription required for correct chromatin organization in sperm. |
ChIP-chip (promoter microarray), Hsf2 knockout mouse, RT-PCR, immunofluorescence, TUNEL assay |
Proceedings of the National Academy of Sciences of the United States of America |
High |
18682557
|
| 2008 |
HSF1 and HSF2 are both bound to the Hspa1b (hsp70.1) promoter in epididymal spermatozoa (gene bookmarking), with HSF2 binding increasing from early to late spermatids, suggesting a mechanism for rapid transcription-competence during zygotic genome activation after fertilization. |
Chromatin immunoprecipitation (ChIP), Western blot, immunofluorescence |
Biology of reproduction |
Medium |
18434628
|
| 2008 |
HSF2 directly interacts with PRC1 (Protein Regulating Cytokinesis 1) specifically during mitosis; PRC1 co-localizes with HSF2 during mitosis and is associated with the hsp70i promoter during this phase, suggesting HSF2-PRC1 interaction provides a mechanistic basis for the cytokinesis defects observed in HSF2-null cells. |
Co-immunoprecipitation, co-localization by immunofluorescence, chromatin immunoprecipitation |
Experimental cell research |
Medium |
18570919
|
| 2011 |
HSF2 and HSF4 both bind to discontinuous HSE sequences in the HIF-1α promoter and cooperate to maintain HIF-1α transcription in a repressed state; downregulation of either HSF activates HIF-1α transcription, and overexpression of either displaces the other from the promoter, showing a competitive balance is required. |
Genome-wide EST screen, ChIP, promoter reporter assay, siRNA knockdown, overexpression |
Oncogene |
Medium |
21258402
|
| 2012 |
A heterozygous missense mutation R502H in human HSF2 causes complete loss of HSF2 transcriptional function and suppresses wild-type HSF2 function through a dominant-negative mechanism, establishing a link between HSF2 loss-of-function and idiopathic azoospermia. |
Sequencing of patient cohort, functional transcriptional assay of mutant vs. wild-type HSF2 |
Human genetics |
Medium |
23064888
|
| 2014 |
HSF2 expression declines during mitosis, and this decline allows HSF1 and RNA polymerase II to access condensed chromatin for stress-inducible Hsp expression; HSF2-deficient cells show reduced mitotic errors and improved survival upon acute stress, demonstrating that HSF2 normally restricts stress-inducible transcription during mitosis. |
HSF2 knockout/knockdown cells, immunofluorescence, ChIP, flow cytometry (mitotic errors, apoptosis), RT-PCR |
The Journal of cell biology |
High |
25202032
|
| 2015 |
HSF2 negatively autoregulates its own transcription by binding to an HSE in its own promoter (~1.5 kb downstream of TSS), forming a negative autoregulatory loop. |
Luciferase reporter assay, ChIP, RT-PCR after HSF2 transfection |
International journal of molecular medicine |
Medium |
26260034
|
| 2016 |
Crystal structures of the human HSF2 DNA-binding domain (DBD) bound to DNA reveal a C-terminal helix that directs wrapping of the coiled-coil domain around DNA, exposing paralog-specific DBD surface sequences for differential post-translational modifications and cofactor interactions; a direct interaction between HSF1 and HSF2 through their coiled-coil domains was also demonstrated. |
X-ray crystallography, co-immunoprecipitation of HSF1-HSF2 coiled-coil interaction |
Nature structural & molecular biology |
High |
26727490
|
| 2017 |
DOX-induced mitochondrial ROS activate ERK1/2, which promotes HSF2 nuclear translocation and deSUMOylation, leading to HSF2 binding to the AT1R promoter and upregulating AT1R expression, contributing to cardiomyocyte apoptosis and cardiotoxicity. |
Immunofluorescence (nuclear translocation), DNA-binding assay, siRNA knockdown, overexpression, in vitro and in vivo cardiomyocyte models |
Journal of cellular physiology |
Medium |
28295305
|
| 2017 |
MEL18 inhibits SUMO-1-mediated SUMOylation of HSF2 (specifically at lysine 82) by interacting with UBC9 and blocking its activity; loss of HSF2 SUMOylation activates IGF-IIR transcription and induces cardiac hypertrophy; angiotensin II receptor blockade restores HSF2 SUMOylation. |
Co-immunoprecipitation, SUMOylation assay, site-directed mutagenesis (K82), Western blot, in vivo spontaneously hypertensive rat model |
International journal of cardiology |
Medium |
29180262 29270451
|
| 2017 |
p53 activation by angiotensin II represses miR-18, which de-represses HSF2 expression; elevated HSF2 then activates IGF-IIR transcription, inducing cardiomyocyte hypertrophy; cardiac-specific miR-18 overexpression protects against hypertension-induced heart failure. |
miRNA target site validation (3'-UTR luciferase), adenovirus-AAV gene transfer, in vitro NRVM model, in vivo transgenic overexpression |
Cell death & disease |
Medium |
28796250
|
| 2019 |
HSF2 interacts with EHMT2 (G9a histone methyltransferase) to epigenetically silence FBP1 via histone methylation, thereby promoting aerobic glycolysis (Warburg effect) and HCC cell proliferation. |
Co-immunoprecipitation, siRNA knockdown, ChIP, proliferation and glycolysis assays |
American journal of cancer research |
Medium |
31497345
|
| 2020 |
HSF1 directly binds an HSE located 1,397 bp upstream of the HSF2 transcription start site in the HSF2 promoter and drives de novo HSF2 mRNA transcription during proteasome inhibition (bortezomib treatment); bortezomib-induced HSF2 localizes in the nucleus, interacts with HSF1, and participates in cancer cell migration. |
Chromatin immunoprecipitation, EMSA, promoter-reporter assay, RT-PCR, immunofluorescence, migration assay |
Cellular and molecular life sciences |
Medium |
32607595
|
| 2021 |
Endogenous HSF2 co-precipitates with ATP-bound (closed-form) HSP90, mirroring HSF1's known interaction with HSP90; treatment with gambogic acid or gambogenic acid disrupts both HSP90-HSF1 and HSP90-HSF2 interactions and induces a thiol-dependent heat shock response that is HSF1-dependent. |
Co-immunoprecipitation with HSP90 mutants, HSF1/HSF2 knockout cells, immunoblotting |
Cell stress & chaperones |
Medium |
34331200
|
| 2022 |
CBP/EP300 acetyltransferases directly interact with HSF2 and acetylate it, leading to HSF2 protein stabilization; loss of CBP/EP300 function (as in Rubinstein-Taybi syndrome) reduces HSF2 levels and disrupts a CBP/EP300-HSF2-N-cadherin cascade required for neuroepithelial integrity in cerebral organoids. |
Co-immunoprecipitation, acetylation assay, patient-derived iPSC organoids, 2D/3D cellular models, Western blot |
Nature communications |
High |
36385105
|
| 2022 |
HSF2 physically and functionally interacts with HSF1 across diverse cancer types; HSF1 and HSF2 share notably similar chromatin occupancy and co-regulate a common set of target genes (including HSPs and non-canonical cancer-supporting genes); loss of HSF2 impairs response to nutrient stress and reduces tumor progression in xenografts. |
Co-immunoprecipitation, ChIP-seq, xenograft tumor models, CRISPR/siRNA loss-of-function |
Science advances |
High |
35294249
|
| 2025 |
HDAC1 interacts with HSF2 and destabilizes the HSF2 protein through its catalytic deacetylase activity, driving HSF2 poly-ubiquitination and proteasomal degradation under both normal and stress conditions; HDAC1 and HSF2 co-localize in developing mouse cortex and human cerebral organoids. |
Unbiased co-immunoprecipitation screen, catalytic mutant analysis, ubiquitination assay, proteasome inhibitor rescue, immunohistochemistry in mouse cortex and human organoids |
Cell stress & chaperones |
High |
40318841
|
| 2025 |
TGF-β signaling downregulates HSF2 expression to enable acquisition of an invasive phenotype in breast cancer; ectopic HSF2 expression inhibits TGF-β-mediated EMT gene expression and invasive properties; temporal HSF2 downregulation is required for EMT activation, while sustained HSF2 promotes proliferation over invasion. |
Cell-based models, in vivo zebrafish xenografts, ectopic expression, human patient tissue analysis (IHC), RT-PCR |
Science advances |
Medium |
40901953
|
| 2026 |
HSF2 forms a genotoxic stress-responsive axis with its client chaperone HSP110; HSF2 loss increases DNA damage and IR sensitivity by impairing RNA Pol II processivity and CTD phosphorylation at serine 7, leading to transcriptional dysregulation, replication conflicts, altered pre-mRNA splicing, and reduced DNA repair gene expression; in vivo, HSF2 loss accelerates IR-induced T cell lymphoma. |
HSF2/HSP110 knockout cells, irradiation assays, RNA Pol II ChIP, CTD phosphorylation assays (Western blot), pre-mRNA splicing analysis, in vivo mouse lymphoma model |
The Journal of cell biology |
High |
41995727
|